WebJun 7, 2024 · Device: Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic, drug-refractory PsAF. Treatment will include the isolation of pulmonary veins (PVIs), and isolation of the left atrial posterior wall (PWI). A right atrial cavo-tricuspid line for bi-directional block may be performed at discretion and clinical ...
FDA Approval: THERMOCOOL SMARTTOUCH® SF Biosense …
WebAug 18, 2024 · The FDA previously approved the Arctic Front Advance, Arctic Front Advance Pro and The Freezor MAXTM Cardiac Cryoablation Catheters. This approval expands indications to treat patients with ... Atrial fibrillation (AF) is a complex arrhythmia; its precise mechanisms remain unclear, and the clinical presentation, arrhythmia characteristics, and underlying pathophysiology are variable. The arrhythmia has been classified in various ways based on electrocardiography (ECG) or clinical criteria. Because … See more This guidance document addresses study design issues associated with catheter ablation devices intended for treatment of atrial fibrillation. These devices (product code, LPB, Electrode, Percutaneous, Conduction Tissue … See more FDA believes that, in general, randomized, controlled trials reflect the least burdensome means of collecting clinical data in support of safety and effectiveness for catheter devices intended to treat AF. In considering … See more The issues identified in this guidance document represent those that we believe should be addressed before your device can be marketed. In developing the guidance, we carefully considered the relevant statutory … See more Primary Effectiveness Endpoint In the future, it may be feasible to demonstrate that ablation therapies for AF positively affect disease … See more book by colleen
Pulsed Field Ablation and Pulsed Field ... - ClinicalTrials.gov
WebJun 8, 2016 · FORM FDA 3881 (8/14) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2024 See PRA Statement below. 510(k) Number (if known) K153272 Device Name Intracept … WebProduct not FDA approved. Not approved for sale in the US. For educational purposes only. Irreversible electroporation 2 The mechanism of action for pulsed field ablation is irreversible electroporation (IRE). Unlike thermal ablation that causes cell death by local tissue temperature, pulsed field ablation applies ultra-rapid electrical pulses ... WebAug 5, 2008 · Catheter Ablation Devices for Treatment of Atrial Flutter . Document issued on: August 5, 2008 . ... FDA's guidance documents, including this guidance, do not establish legally enforceable godmother\\u0027s hb